GGrantIndex
← Search

HERPEVAC TRIAL FOR WOMEN: A PHASE III VACCINE STUDY TO PREVENT GENITAL HERPES IN

$246,066M01FY2007RRNIH

University Of Alabama At Birmingham, Birmingham AL

Investigators

Linked publications & trials

View original record on NIH RePORTER →